 Featured News February 25, 2013
Med BioGene Provides Update on Litigation With Signal Genetics LLC and Respira Health LLC
January 23, 2013
Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx™ Clinical Studies; Precision Therapeutics Prepares for Commercial Launch
|
News Archives 2007
September 24, 2007
Med BioGene Appoints Dr. Melanie M. Mahtani as Executive Advisor, Commercial Development
September 10, 2007
Med BioGene Inc. Engages Peterson Capital to Provide Investor and Financial Relations Services
July 30, 2007
Med BioGene Inc. Dr. Nathan Yoganathan, President and Chief Scientific Officer, Transitions to Senior Advisory Role; Dr. Bradley McLean Appointed Chief Scientific Officer
June 18, 2007
Med BioGene Inc. to Close Second and Final Tranche of Private Placement on June 29, 2007
March 19, 2007
Med BioGene Announces Collaboration to Develop Genetic Biomarkers for Lymphoma and Leukemia for use in Diagnosis, Prognosis and Drug Development
February 27, 2007
Med BioGene Appoints Dr. Richard C. Cook to its Scientific Advisory Board
February 15, 2007
Med BioGene Enters Development Phase For Genetic Screening Test For Colorectal Cancer
February 15, 2007
Med BioGene Engages The Howard Group Inc. to Provide Investor and Financial Relations Services
February 08, 2007
Med BioGene Receives $307,000 Contribution from National Research Council Canada to Develop Genetic Biomarkers for Cardiovascular Disease
February 01, 2007
Med BioGene Announces Further Promising Results on the Diagnostic Value of its Lymphoma Genetic Biomarkers
|
E-MAIL ALERTS
Subscribe to our e-mail news alerts
|
Home 
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer